We have reorganized the management within LUCC and also got new members plus a new vice coordinator since the beginning of the year. The former board and the executive group have been merged to an operational board. This will streamline the organization and adapt it to current needs.
The current members of the Board and Scientific Advisory board are:
LUCC Coordinator 20240301-270228
Mats Jerkeman, Professor
Board (9 members) 20250101-20271231
Mats Jerkeman, Chair & Coordinator
Charlotte Rolny, Vice chair & Vice Coordinator
Lao Saal, Academic representative Faculty of Medicine, Lund University
Vinay Swaminathan, Academic representative Faculty of Medicine, Lund University
Mef Nilbert Academic representative Faculty of Medicine, Lund University
Sara Ek, Academic representative Faculty of Engineering, Lund University
Pamela Buchwald, Representative Skåne University Hospital Comprehensive Cancer Centre
Carina Bernardo, Representative Future Faculty
vacant, PhD Student Representative
Co-opted member: Cecilia Jädert, Innovation
Scientific Advisory Board
Prof Lars Bullinger, Medical Director of the Department of Hematology, Oncology and Tumorimmunology, DE
Prof Alex Molassiotis,University of Derby, vårdvetenskaplig inriktning (20230101 – 20251231), UK
Prof Mark Middleton, Director of the CRUK Oxford, Oxford University, UK
Prof. Inge Marie Svane, National Center for Cancer Immune Therapy, CCIT-DK Copenhagen University Hospital, Herlev, Denmark